| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PLUS THERAPEUTICS, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 24,073 | 22 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PSTV | PLUS THERAPEUTICS, INC. | 22 Feb 2024 | 1 | $0 | 4 | Chief Medical Officer | 26 Feb 2024, 18:26 |
| PSTV | PLUS THERAPEUTICS, INC. | 15 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 17 Feb 2023, 15:30 |
| PSTV | PLUS THERAPEUTICS, INC. | 11 Nov 2021 | 1 | $0 | 4/A | CHIEF MEDICAL OFFICER | 28 Mar 2022, 18:59 |
| PSTV | PLUS THERAPEUTICS, INC. | 11 Nov 2021 | 0 | $0 | 3 | CHIEF MEDICAL OFFICER | 24 Nov 2021, 20:07 |